Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2557
H.R.2557: Prostate Cancer Misdiagnosis Elimination Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced May 19, 2017
- Latest Major Action Dec. 6, 2017
Bill Sponsor
Bill Cosponsors
6 (3 Democrats, 3 Republicans)
Bill Versions
- Reported in House - Dec. 6, 2017
- Introduced in House - May 19, 2017
Bill Summary
Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Congressional Budget Office Estimate
Bill Actions
| Date | Description |
|---|---|
| Dec. 6, 2017 |
Placed on the Union Calendar, Calendar No. 331.
|
| Dec. 6, 2017 |
Committee on Ways and Means discharged. |
| Dec. 6, 2017 |
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.
|
| Oct. 4, 2017 |
Ordered to be Reported (Amended) by Voice Vote.
|
| Oct. 4, 2017 |
Committee Consideration and Mark-up Session Held.
|
| Sept. 13, 2017 |
Forwarded by Subcommittee to Full Committee by Voice Vote .
|
| Sept. 13, 2017 |
Subcommittee Consideration and Mark-up Session Held.
|
| June 1, 2017 |
Referred to the Subcommittee on Health.
|
| May 26, 2017 |
Referred to the Subcommittee on Health.
|
| May 19, 2017 |
Referred to House Ways and Means
|
| May 19, 2017 |
Referred to House Energy and Commerce
|
| May 19, 2017 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| May 19, 2017 |
Introduced in the House by Larry Bucshon (R-Ind.) |